Skip to content

Released Nov 13, 2013, during market hours

10-Q filed Nov 13, 2013, 44 days after period end · 0001144204-13-060976

Q3 2013 · 10-Q
Revenue$5.95M+9.9% vs Q3 2012+206.8% vs Q2 2013
Net Income$1.24M+15.2% vs Q3 2012N/M vs Q2 2013
EPS Diluted$0.08+14.3% vs Q3 2012N/M vs Q2 2013
Gross Profit$3,817,000+12.3%
Operating Income$1,239,000+15.5%
Operating Cash Flowderived-$3,260,000N/M
Free Cash Flowderived-$3,334,000N/M
Margins · derived
Gross margin64.2%+1.4 pt vs Q3 2012
Operating margin20.8%+1.0 pt vs Q3 2012
Net margin20.8%+1.0 pt vs Q3 2012

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2013Q3 2012Q3 2011Q3 2010
Revenue$5.95M$5.42M$5.08M$5.20M
Net Income$1.24M$1.07M$1.11M$947.00K
EPS Diluted$0.08$0.07$0.07$0.06

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR